Follow
Jacob S. Aday
Title
Cited by
Cited by
Year
Long-term effects of psychedelic drugs: A systematic review
JS Aday, CM Mitzkovitz, EK Bloesch, CC Davoli, AK Davis
Neuroscience & Biobehavioral Reviews 113, 179-189, 2020
1812020
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
AK Schlag, JS Aday, I Salam, JC Neill, DJ Nutt
Journal of Psychopharmacology 36 (3), 258-272, 2022
1362022
Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects
JS Aday, AK Davis, CM Mitzkovitz, EK Bloesch, CC Davoli
ACS Pharmacology & Translational Science, 2021
1182021
Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials
JS Aday, BD Heifets, SD Pratscher, E Bradley, R Rosen, J Woolley
Psychopharmacology, 2022
952022
2019: A year of expansion in psychedelic research, industry, and deregulation
JS Aday, EK Bloesch, CC Davoli
Drug Science, Policy and Law 6, 2050324520974484, 2020
472020
2018: A watershed year for psychedelic science
JS Aday, CC Davoli, EK Bloesch
Drug Science, Policy and Law, 2019
342019
Extended testing with the dot-probe task increases test–retest reliability and validity
JS Aday, JM Carlson
Cognitive Processing 20 (1), 65-72, 2019
322019
Psychedelics and virtual reality: Parallels and applications
JS Aday, CC Davoli, EK Bloesch
Therapeutic Advances in Psychopharmacology, 2020
292020
Neural mechanisms of emotions and affect
JS Aday, W Rizer, J Carlson
Emotions and Affect in Human Factors & Human-Computer Interaction 1, 27-87, 2017
282017
Neurotensin NTS1 and NTS2 receptor agonists produce anxiolytic-like effects in the 22-kHz ultrasonic vocalization model in rats
F Steele, S Whitehouse, JS Aday, A Prus
Brain Research, 2017
272017
Can psychedelic drugs attenuate age-related changes in cognition and affect?
JS Aday, EK Bloesch, CC Davoli
Journal of Cognitive Enhancement, 1-9, 2019
222019
Temporal dynamics in attention bias: Effects of sex differences, task timing parameters, and stimulus valence
JM Carlson, JS Aday, D Rubin
Cognition and Emotion 33 (6), 1271-1276, 2019
202019
Beyond LSD: A broader psychedelic zeitgeist during the early to mid-20th century
JS Aday, EK Bloesch, CC Davoli
Journal of Psychoactive Drugs, 1-8, 2019
202019
Emerging Challenges for Psychedelic Therapy
JS Aday, RL Carhart-Harris, JD Woolley
JAMA Psychiatry, 2023
192023
Structural MRI-based measures of neuroplasticity in an extended amygdala network as a target for attention bias modification treatment outcome
JS Aday, JM Carlson
Medical Hypotheses 109, 6-16, 2017
192017
Psychedelic drugs and perception: A narrative review of the first era of research
JS Aday, JR Wood, EK Bloesch, CC Davoli
Reviews in the Neurosciences, 2021
142021
In the presence of conflicting gaze cues, fearful expression and eye-size guide attention
JM Carlson, JS Aday
Cognition and Emotion 32 (6), 1178-1188, 2018
142018
Personal psychedelic use is common among a sample of psychedelic therapists: Implications for research and practice
JS Aday, Z Skiles, N Eaton, L Fredenburg, M Pleet, J Mantia, ER Bradley, ...
Psychedelic Medicine, 2023
102023
Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA
B Sessa, JS Aday, S O’Brien, HV Curran, F Measham, L Higbed, DJ Nutt
Journal of Psychopharmacology 36 (3), 360-367, 2022
102022
Changes in prefrontal cortex near infrared spectroscopy activity as a function of difficulty in a visual P300 paradigm
W Rizer, JS Aday, JM Carlson
Journal of Near Infrared Spectroscopy 26 (4), 222-228, 2018
72018
The system can't perform the operation now. Try again later.
Articles 1–20